Your search for esrd returned 4 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

News remove
ACR/ARHP Annual Meeting 2015 remove

Your search for esrd returned 4 results

Sort Results:

Relevant Recent
ACR/ARHP Annual Meeting 2015

Is Non-TNF Targeted Tx Better Than a Second Anti-TNF Drug?

A non-TNF-targeted biologic showed better efficacy than a second anti-TNF agent for patients with rheumatoid arthritis and insufficient response to TNF-inhibitors, according to research presented at the 2015 ACR/ARHP Annual Meeting.
ACR/ARHP Annual Meeting 2015

Tofacitinib Efficacy Unaffected by Methotrexate Dose in RA

Clinical efficacy of the oral Janus kinase inhibitor tofacitinib at Month 6 was greater than placebo and "appeared similar regardless of methotrexate dose" in patients with rheumatoid arthritis a post-hoc analysis presented at the 2015 ACR/ARHP Annual Meeting has found.
ACR/ARHP Annual Meeting 2015

Long-term Etanercept Boasts Better Retention Rates than Adalimumab in RA

Long-term etanercept is associated with modestly better treatment retention rates than adalimumab among patients with rheumatoid arthritis (RA), according to an analysis of data from the RHUMADATA® clinical registry and database presented at the 2015 ACR/ARHP Annual Meeting.